Elsevier Launches SciVal Funding Solution to Help U.S. Research Institutions Better Compete for Grants
28 Setembro 2009 - 2:11AM
PR Newswire (US)
AMSTERDAM, September 28 /PRNewswire-FirstCall/ -- - Optimizes Grant
Seeking Process by Integrating Current Funding Opportunities with
Historical Award Information and Publication Data Elsevier, a
world-leading publisher of scientific, technical and medical
information products and services, today announced the launch of
SciVal Funding, a comprehensive funding intelligence solution for
U.S. research institutions. The platform helps researchers locate
the most appropriate grant opportunities in order to maximize their
potential to receive funding. Securing funding is an essential step
in a researcher's workflow. Due to the labor intensive and
demanding nature of the process, researchers may spend up to one
third of their time seeking grant opportunities and preparing
proposals - often with limited success. As research becomes
increasingly multidisciplinary, collaborative and international,
securing funding is inherently more competitive. Recognizing these
challenges, SciVal Funding is designed to optimize the pre-award
stages of the process, leading researchers and research
administrators to grants with the greatest potential for success by
integrating current funding opportunities with publication
information and historical award data. SciVal Funding allows users
to routinely search over 5,000 grant sources, including federal
funding bodies and private foundations. Updated daily, funding
opportunities can be explored by subject area, award type, deadline
or amount. In addition, by fully cataloguing limited submission
programs, research administrators may set up necessary internal
review mechanisms in a timely way. Access to a comprehensive pool
of funding opportunities as well as the ability to uncover new
sources of financial support is especially critical in these
difficult economic times. Moreover, the solution provides
customized recommendations and alerts by matching funding
opportunity data to pre-populated research profiles that are
continuously updated. This eliminates the need to create a summary
of each investigator's body of work and allows users to run
searches on their own as well as other researchers' profiles. These
recommendations can also serve as guideposts to junior faculty
regarding which funding sources to pursue, particularly as the
early grants in a young researcher's career are critical to
building a solid track record. Another advantage of the solution is
the integrated funding award information. The historical data on
what grants were awarded to which researcher and at which specific
institution, provides vital insight into the funding environment.
This intelligence enables researchers to more accurately estimate
their award chances, tailor their proposal, find collaborators and
ultimately better compete for grants. Research administrators may
also use this award information for performance measurement,
evaluation and strategic planning purposes. "The fragmented and
fast-changing nature of today's research funding environment,
combined with the limited time and resources of researchers, is
driving a need to rethink the current approach to the grant-seeking
process," explained Josine Stallinga for Elsevier's Academic and
Government Group. "SciVal Funding helps users make smarter
decisions when it comes to determining which research grants to
pursue as well as the most appropriate way to pursue them.
Ultimately, reducing time spent searching for funding enables
scientists to focus on what's really important -- their research."
On June 30, 2009, Elsevier hosted a webcast discussing the
challenges of today's funding environment and offering an overview
of the SciVal Funding solution. To view a recording of the virtual
event, please visit http://info.funding.scival.com/webcast3/, and
for information on the tool, please visit
http://www.info.funding.scival.com/. About the Elsevier SciVal
Suite The SciVal suite of services delivers intelligence solutions
to help the academic and government research communities evaluate,
establish and execute their research strategies more effectively.
The suite currently includes SciVal Spotlight and SciVal Funding.
With traditional research performance measurement options unable to
capture the reality of today's multidisciplinary scientific
landscape, the SciVal Spotlight tool is designed to provide
research managers with a more accurate picture of any institution's
unique research strengths and opportunities. SciVal Funding is an
online funding intelligence solution that enables researchers and
research administrators to better compete for research funding. The
tool provides access to over 5,000 funding sources and includes
targeted recommendations based on pre-populated research profiles
as well as an extensive history of awarded grants. For more
information on the SciVal Suite, please visit
http://www.scival.com/. About Elsevier Elsevier is a world-leading
publisher of scientific, technical and medical information products
and services. The company works in partnership with the global
science and health communities to publish more than 2,000 journals,
including The Lancet (http://www.thelancet.com/) and Cell
(http://www.cell.com/), and close to 20,000 book titles, including
major reference works from Mosby and Saunders. Elsevier's online
solutions include ScienceDirect (http://www.sciencedirect.com/),
Scopus (http://www.scopus.com/), Reaxys (http://www.reaxys.com/),
MD Consult (http://www.mdconsult.com/) and Nursing Consult
(http://www.nursingconsult.com/), which enhance the productivity of
science and health professionals, and the SciVal suite
(http://www.scival.com/) and MEDai's Pinpoint Review
(http://www.medai.com/), which help research and health care
institutions deliver better outcomes more cost-effectively. A
global business headquartered in Amsterdam, Elsevier
(http://www.elsevier.com/) employs 7,000 people worldwide. The
company is part of Reed Elsevier Group PLC
(http://www.reedelsevier.com/), a world-leading publisher and
information provider. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York
Stock Exchange). Jessica Disch +1-212-752-8338 Amanda Sham
+1-212-752-8338 DATASOURCE: Elsevier CONTACT: Jessica Disch,
+1-212-752-8338, ; Amanda Sham, Phone: +1-212-752-8338,
Copyright